A study of the pathogenesis and prevention of central pontine myelinolysis in a rat model

Journal of International Medical Research

Volumn 34, Issue 3, 2006, Pages 264-271

  Ke, Q H ^a   Liang, T B ^a   Tu, J ^a   Zheng, S S ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Blood brain barrier; Central pontine myelinolysis; Dexamethasone; Inducible nitric oxide synthase; Pathogenesis; Prevention

Indexed keywords

DEXAMETHASONE; EVANS BLUE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VASOPRESSIN TANNATE; WATER;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN TISSUE; CENTRAL PONTINE MYELINOLYSIS; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; EARLY INTERVENTION; EXTRAVASATION; FISHER EXACT TEST; HISTOPATHOLOGY; HYPONATREMIA; MALE; NEUROPATHOLOGY; NONHUMAN; PERMEABILITY; PROTEIN EXPRESSION; RAT; RAT STRAIN; SODIUM BLOOD LEVEL; WESTERN BLOTTING;

EID: 33745944464     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000603400305     Document Type: Article

References (15)

1. Ashrafian H, Davey P: A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol 2001; 8: 103-109.
2. Castello L, Pirisi M, Sainaghi PP, Bartoli E: Hyponatremia in liver cirrhosis: pathophysiological principles of management. Dig Liver Dis 2005; 37: 73-81.
3. Lampl C, Yazdi K: Central pontine myelinolysis. Eur Neurol 2002; 47: 3-10.
4. Ozgur-Ilhan I, Demirbas H, Yalcin GA, Yucesan C, Dogan YB: Alcoholic case of central pontine myelinolysis with mainly cerebellar signs. Eur Addict Res 2005; 11: 155-156.
5. De Keyser J, Zwanikken CM, Zorgdrager A, Oenema D, Boon M: Treatment of acute relapses in multiple sclerosis at home with oral dexamethasone: a pilot study. J Clin Neurosci 1999; 6: 382-384.
6. Richert ND, Ostuni JL, Bash CN, Leist TP, McFarland HF, Frank JA: Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 2001; 7: 49-58.
7. Martin RJ: Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004; 75 (Suppl 3): 22-28.
8. Ruzek KA, Campeau NG, Miller GM: Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. Am J Neuroradiol 2004; 25: 210-213.
9. Dohgu S, Yamauchi A, Nakagawa S, Takata F, Kai M, Egawa T, et al: Nitric oxide mediates cyclosporine-induced impairment of the blood-brain barrier in cocultures of mouse brain endothelial cells and rat astrocytes. Eur J Pharmacol 2004; 505: 51-59.
10. Golde S, Coles A, Lindquist JA, Compston A: Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro. Eur J Neurosci 2003; 18: 2527-2537.
11. Liu JS, Zhao ML, Brosnan CF, Lee SC: Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001; 158: 2057-2066.
12. Vincent VA, De Groot CJ, Lucassen PJ, Portegies P, Troost D, Tilders FJ, et al: Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients. AIDS 1999; 13: 317-326.
13. Koedel U, Bernatowicz A, Paul R, Frei K, Fontana A, Pfister HW: Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann Neurol 1995; 37: 313-323.
14. Sterns RH, Cappuccio JD, Silver SM, Cohen EP: Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994; 4: 1522-1530.
15. Abbasoglu O, Goldstein RM, Vodapally MS, Jennings LW, Levy MF, Husberg BS, et al: Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 1998; 12: 263-269.